ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Status: Recruiting
Location: See all (19) locations...
Study Type: Observational
SUMMARY
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• All adult patients (≥ 18 years of age) undergoing PCI for de novo CAD using DCB
Locations
United States
Arizona
Banner University Medical Center
NOT_YET_RECRUITING
Phoenix
Florida
Holy Cross Health Fort Lauderdale
NOT_YET_RECRUITING
Fort Lauderdale
Georgia
Emory Saint Joseph's Hospital
RECRUITING
Atlanta
Emory University Hospital
RECRUITING
Atlanta
Emory University Hospital Midtown
RECRUITING
Atlanta
Emory Johns Creek Hospital
RECRUITING
Johns Creek
Massachusetts
Brigham and Women's Hospital
NOT_YET_RECRUITING
Boston
Tufts Medical Center
NOT_YET_RECRUITING
Boston
Minnesota
Allina Health Minneapolis Heart Institute
NOT_YET_RECRUITING
Minneapolis
North Carolina
Sanger Heart & Vascular Institute
NOT_YET_RECRUITING
Charlotte
Duke University Hospital
NOT_YET_RECRUITING
Durham
New York
Montefiore Medical Center
NOT_YET_RECRUITING
New York
New York-Presbyterian/Weill Cornell Medical Center
NOT_YET_RECRUITING
New York
The Mount Sinai Hospital
NOT_YET_RECRUITING
New York
St. Francis Hospital & Heart Center
NOT_YET_RECRUITING
Roslyn
Ohio
University Hospitals Cleveland Medical Center
NOT_YET_RECRUITING
Cleveland
Tennessee
Vanderbilt University Medical Center
NOT_YET_RECRUITING
Nashville
Other Locations
Germany
Universitatsklinikum des Saarlandes
NOT_YET_RECRUITING
Homberg (efze)
Serbia
University Clinical Centre of Serbia
NOT_YET_RECRUITING
Belgrade
Contact Information
Primary
Daniel Gold, MD
daniel.alexander.gold@emory.edu
314-761-3396
Time Frame
Start Date: 2026-06
Estimated Completion Date: 2031-05
Participants
Target number of participants: 5000
Treatments
Adults undergoing PCI with drug-coated balloons (DCB) for de novo coronary artery disease
All adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
Related Therapeutic Areas
Sponsors
Leads: Emory University